"support the potential for Blenrep combinations to become standard of care" in multiple myeloma patients at or after their first relapse. The company previously teased the overall survival (OS ...

In terms of when, let's say for instance, a patient develops symptoms of multiple myeloma, there are now studies that have shown that some early traces of myeloma, genetic alterations that lead to ...

Despite these challenges, advances in the field are improving the outlook for people diagnosed with multiple myeloma. As evidence, the five-year overall survival rate in the United States has ...

Multiple myeloma (MM) is a malignancy of terminally differentiated B cells. The diagnosis requires the presence of ≥ 10 % clonal plasma cells (PC) in the bone marrow or an extramedullary plasmacytoma ...

Multiple myeloma is part of the spectrum of diseases ranging from MGUS to plasma cell leukemia, and similar to MGUS, is characterized by proliferation of a plasma cell clone and subsequent ...

Introduction: Plasma cell quantification in bone marrow is important for diagnosis, prognosis, and treatment of plasma cell diseases ... 32 -85) years. The diagnoses were multiple myeloma in 61%, ...

Prognosis is the prediction of the probable outcome of an individual's current medical condition. A prognosis is made on the basis of the normal course of a disease, the individual's physical and ...